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Background
Systemic lupus erythematosus (SLE) is a systemic autoim-
mune disorder that commonly affects the heart, resulting
in a 7 to 9 times greater incidence of cardiovascular disease
(CVD) in SLE patients compared to healthy controls.
Female patients with SLE between 35 and 44 years old
have an incidence of myocardial infarction over 50 times
greater than that observed in the Framingham cohort. The
clinical utility of cardiovascular magnetic resonance (CMR)
first-pass perfusion for assessment of myocardial ischaemia
is well-established. We hypothesised that CMR including
stress first-pass perfusion would be able to detect coronary
microvascular disease and subtle functional abnormalities
in SLE and aimed to detect myocardial ischaemia in SLE
using adenosine stress perfusion CMR.
Methods
29 SLE patients (28 female, mean age 42 ± 9 years) and 29
matched controls (28 female, mean age 42 ± 9 years) with-
out previously known cardiovascular disease underwent
CMR at 1.5T including cine, tagging, T1 mapping, T2-
weighted, perfusion imaging, late gadolinium enhance-
ment (0.15mmol/kg gadoteric acid - Dotarem®) and ECV
quantification. Comorbid status, disease activity index and
duration of disease were recorded for each subject.
Results
SLE patients were matched with controls for age, sex
and comorbidity (Table 1). Myocardial perfusion reserve
index (MPRI) was lower in SLE compared to controls
(1.4 ± 0.2 vs. 1.9 ± 0.4, p<0.001), shown in Table 2. A
third of lupus patients had visual evidence of non-seg-
mental subendocardial perfusion defects, in keeping
with microvascular dysfunction. No segmental perfusion
defects were observed to suggest presence of epicardial
coronary artery disease. There was no significant differ-
ence in LV size, mass and ejection fraction between SLE
patients and controls. Peak systolic circumferential
strain (-17.2 ± 1.7 vs. -19.4 ± 1.2, p<0.001) and peak dia-
stolic strain rate (78 ± 24 vs. 118 ± 15 s-1, p<0.001) were
impaired in SLE patients. In SLE, MPRI showed a signif-
icant correlation with peak systolic strain (R= -0.76,
p<0.001) and peak diastolic strain rate (R= 0.65,
p<0.001), depicted in Figure 1.
Conclusions
Myocardial perfusion is impaired in patients with SLE
with no known heart disease. In these patients, impaired
MPRI was associated with abnormal myocardial defor-
mation characteristics. It is likely that chronic disease
activity and myocardial inflammation results in abnorm-
alities in microvascular function which predate the
development of myocardial functional derangements.
CMR is an important tool for assessment of subclinical
myocardial disease in SLE.
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Table 1 Baseline characteristics of SLE patients and controls
Controls N=29 SLE N=29 P value
Female sex, n (%) 28 (97) 28 (97) 1.00
Age, years 42 ± 9 42 ± 9 0.69
Hypertension, n (%) 0 0 -
Diabetes, n (%) 0 0 -
Hyperlipidaemia, n (%) 1 (3) 0 -
BMI, kg/m2 23 ± 3 28 ± 6 <0.001
Chloroquine, n (%) N/A 20 (69) -
Prednisolone, n (%) N/A 14 (48) -
Azathioprine, n (%) N/A 8 (29) -
Mycophenolate mofetil, n (%) N/A 5 (17) -
Methotrexate, n (%) N/A 1 (3) -
Leflunomide, n (%) N/A 1 (3) -
Rituximab, n (%) N/A 1 (3) -
HRT/OCP 9 (31) 9 (31) 1.00
SLEDAI (median, IQR) N/A 9 (1-16) -
ESR, mm/hr (median, IQR) N/A 6 (3-12) -
CRP, mg/L (median, IQR) 1 (1-1) 4 (2-9) <0.001
Duration of SLE, years (median, IQR) N/A 9 (-12) -
Duration of DMARDs, years (median, IQR) N/A 5 (3-8) -
Continuous data are mean ± SD unless otherwise indicated. Categorical data are frequency (percent) unless otherwise indicated. BMI, body mass index; CRP, C-
reactive protein; DMARD, disease modifying anti-rheumatic drug(s); ESR, erythrocyte sedimentation rate; HRT/OCP, hormone replacement therapy or oral
contraceptive pill; IQR, interquartile range; SLE, systemic lupus erythematosus; SLEDAI, systemic lupus erythematosus disease activity index
Table 2 Myocardial structure, function and perfusion in SLE patients and controls
Controls N=29 SLE N=29 P value
LVEDV indexed to BSA, ml/m2 80 ± 15 78 ± 12 0.71
LVESV indexed to BSA, ml/m2 22 ± 6 20 ± 6 0.23
LVEF, % 74 ± 5 72 ± 6 0.54
LV Mass indexed to BSA, g/m2 51 ± 10 48 ± 10 0.18
LA size, mm 26 ± 4 32 ± 5 <0.001
Mid SA circumferential strain -19.4 ± 1.2 -17.2 ± 1.7 <0.001
Peak diastolic circumferential strain rate (s-1) 118 ± 15 78 ± 24 <0.001
Presence of LGE (%) 0 10 (43) -
Volume fraction of LGE>2SD (%) 0 2.7 ± 0.3 -
Global myocardial T2 SI Ratio 1.5 ± 0.1 1.7 ± 0.3 0.001
Volume fraction of oedema by T2 (%) 0 17 (7-23) -
Average myocardial T1, ms 959 ± 28 983 ± 30 0.01
Volume fraction of T1>990ms (%) 3 (1-4) 38 (23-50) <0.001
ECV (%) 28.1 ± 2.9 30.6 ± 4.0 0.04
Rest RPP 7, 741 ± 1, 308 9, 028 ± 1, 669 0.002
Rest RPP 11, 474 ± 2, 110 13, 140 ± 2, 537 0.009
MPRI 1.9 ± 0.4 1.4 ± 0.2 <0.001
Proportion of non-segmental perfusion defects (%) 0 9 (31) -
Continuous data are mean ± SD unless otherwise indicated. ECV, extracellular volume; LA, left atrium; LGE, late gadolinium enhancement; LV, left ventricle/
ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; MPRI, myocardial
perfusion reserve index; RPP, rate pressure product; SA, short axis; SI, signal intensity, SLE, systemic lupus erythematosus
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